Elucidating the exact pharmacological mechanism of action (MOA) of Normally happening compounds is usually demanding. Even though Tarselli et al. (60) made the very first de novo synthetic pathway to conolidine and showcased that this naturally occurring compound effectively suppresses responses to equally chemically induced and inflammation-derive